0001093557-16-000548.txt : 20160526 0001093557-16-000548.hdr.sgml : 20160526 20160526202954 ACCESSION NUMBER: 0001093557-16-000548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160525 FILED AS OF DATE: 20160526 DATE AS OF CHANGE: 20160526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOLETTA MARK G CENTRAL INDEX KEY: 0001236389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 161679809 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-05-25 0 0001093557 DEXCOM INC DXCM 0001236389 FOLETTA MARK G 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 1 0 0 0 Common Stock 2016-05-25 4 A 0 5450.0 0.0010 A 17443 D Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock. Included in this number are 14,698 unvested restricted stock units, 5,450 of which were granted on May 25, 2016 and shall vest on May 25, 2017, 4,671 of which were granted on June 3, 2015 and shall vest on June 3, 2016 and 4,577 unvested restricted stock units granted on November 17, 2014 and shall vest through November 17, 2017. By: John Lister For: Mark G. Foletta 2016-05-26